FDA Adverse Event Malfunction Summary report: N

I-STAT PTPLUS CARTRIDGE

MDR report key: 20557262 · Received October 29, 2024

Report

Report Number
2245578-2024-00196
Event Type
Malfunction
Date Received
October 29, 2024
Date of Event
October 16, 2024
Report Date
December 3, 2024
Manufacturer
ABBOTT POINT OF CARE
Product Code
GJS
PMA / PMN Number
K220282
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

APOC INCIDENT: # (B)(4). THE INVESTIGATION WAS COMPLETED ON 25-NOV-2024. A REVIEW OF THE DEVICE HISTORY RECORD (DHR) CONFIRMED THE CARTRIDGE LOT PASSED RELEASE SPECIFICATIONS. RETAINED CARTRIDGE TESTING MET THE ACCEPTANCE CRITERIA IN APPENDIX 1 OF Q04.01.003 REV. AN (PRODUCT COMPLAINT LEVEL 2 AND LEVEL 3 INVESTIGATION PROCEDURE). NO DEFICIENCY HAS BEEN IDENTIFIED.

Additional Manufacturer Narrative · 0

APOC INCIDENT # 964571 APOC LABELING WILL BE EVALUATED DURING THE INVESTIGATION AS PERTAINING TO THE EVENT.

Description of Event or Problem · 0

NA.

Description of Event or Problem · 0

ON 22-OCT-2024, ABBOTT POINT OF CARE WAS CONTACTED BY A CUSTOMER REGARDING I-STAT PT PLUS CARTRIDGES THAT YIELDED A SUSPECTED DISCREPANT RESULT ON A 84 YEAR OLD FEMALE PATIENT IN FOR AN MITRAL VALVE REPLACEMENT. THERE WAS NO ADDITIONAL INFORMATION AVAILABLE AT THE TIME OF THIS REPORT. RETURN PRODUCT IS NOT AVAILABLE FOR INVESTIGATION. METHOD DATE COLLECTED TESTED INR SAMPLE I-STAT 16-OCT-24 11:14 IMMEDIATELY 4.4 FINGERSTICK I-STAT 16-OCT-24 11:14 11:24 2.7 FINGERSTICK AT THIS TIME THERE IS NO REASON TO SUSPECT A MALFUNCTION EXISTS. THE REPORTING DECISION WAS BASED ON LIMITED INFORMATION AVAILABLE THAT SUGGESTS THE PRODUCT WAS NOT PERFORMING WITHIN THE VARIABILITY OF THE ASSAY. THE INVESTIGATION IS UNDERWAY. INTENDED USE: THE I-STAT PTPLUS CARTRIDGE IS INTENDED FOR USE IN THE IN VITRO QUANTITATIVE MEASUREMENT OF THE CLOT TIME OF THE EXTRINSIC COAGULATION PATHWAY WHEN ACTIVATED BY THROMBOPLASTIN IN NON-ANTICOAGULATED WHOLE BLOOD (VENOUS OR CAPILLARY), USING THE I-STAT 1 SYSTEM. MEASUREMENTS OF PROTHROMBIN TIME ARE USED TO AID IN THE MONITORING OF PATIENTS RECEIVING ANTICOAGULANT THERAPY WITH COUMARIN DERIVATIVES. THE I-STAT PTPLUS PT TEST RESULT IS REPORTED IN SECONDS AND AS AN INR. THE TEST IS INTENDED FOR POINT OF CARE USE AND IS FOR PRESCRIPTION USE ONLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
978968 I-STAT PTPLUS CARTRIDGE PTPLUS CARTRIDGE GJS ABBOTT POINT OF CARE NA C24209A

Patients

Seq Age Sex Outcome Treatment
1 84 YR Female